32 results
424B4
APTO
Aptose Biosciences Inc
26 Jan 24
Prospectus supplement with pricing info
5:30pm
trials (e.g., children, the elderly, pregnant women) and the drug’s long-term morbidity and mortality profile. Regulatory authorities may require
8-K
EX-99.1
mb7rninz89evzyl4p
19 Oct 20
Regulation FD Disclosure
7:05am
DEF 14A
rjxcb3p34 2k
8 May 19
Definitive proxy
4:31pm
PRE 14A
1df4n920z0ja28 40
12 Apr 19
Preliminary proxy
12:00am
10-K
e912kqaars
12 Mar 19
Annual report
4:57pm
6-K
EX-99.1
hoo70gc x7
9 May 18
Current report (foreign)
12:20pm